
What smart money is saying about Viking Therapeutics
VKTX
No fund has written a full thesis on Viking Therapeutics in our archive, but 3 fund letters report a position in it, most recently ClearBridge Investments SMID Cap Growth Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
3
Reported positions
0
Bought
2
Sold
3
Letters
Position history
Between Q2 2026 and Q3 2026, 3 fund letters reported a position in Viking Therapeutics, with 2 sells (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 1 | 0 |
| Q2 2026 | 2 | 0 | 1 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 3 positions · 3 moves
- September 2026
“Bloom Energy and Credo Technology saw their market caps eclipse what we believed to be an appropriate level for a SMID strategy, and we subsequently exited the positions. We also exited BJ’s Wholesale Club, Shift4 Payments, SentinelOne and Viking Therapeutics as part of our ongoing effort to reallocate capital toward higher-conviction opportunities or to manage portfolio construction considerations.”
Viking Therapeutics - June 2026
“We have sold four stub positions during the quarter: PDD, Wix, Viking Therapeutics, and Fiverr.”
Viking Therapeutics - June 2026
“We have sold four stub positions during the quarter: PDD, Wix, Viking Therapeutics, and Fiverr.”
Viking Therapeutics
Read the letters behind these Viking Therapeutics positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger